Regeneration therapy with rich platelets plasma for facial rejuvenation
Keywords:
woman, facial rejuvenation, regenerative therapy, rich platelets plasma.Abstract
The case report of a 50 years patient is described who presented signs of facial aging, to request a restoration treatment without surgical intervention, reason why it was decided to apply her the regenerative therapy with rich autologous platelets plasma, keeping in mind that it is an innocuous and lack of complications treatment. Finally, the change was evident and the patient was satisfied with the obtained aesthetic and facial results.
Downloads
References
2. Mendelson B, Wong CH. Changes in the facial skeleton with aging: implications and clinical applications in facial rejuvenation. Aesthetic Plast Surg. 2012;36(4):753-60.
3. Shaw RB, Katzel EB, Koltz PF, Kahn DM, Puzas EJ, Langstein HN. Facial bone density: effects of aging and impact on facial rejuvenation. Aesthet Surg J. 2012;32(8):937-42.
4. Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol. 2010;9(1):66-71.
5. Freshwater MF. The use of platelet-rich plasma in plastic surgery remains unproven. J Plast Reconstr Aesthet Surg. 2013;66(3):311-2.
6. Rodrigues SV, Acharya AB, Thakur SL. Platelet-rich plasma. A review. N Y State Dent J. 2012;78(1):26-30.
7. Pelletier MH, Malhotra A, Brighton T, Walsh WR, Lindeman R. Platelet function and constituents of platelet rich plasma. Int J Sports Med. 2013;34(1):74-80.
8. Sommeling CE, Heyneman A, Hoeksema H, Verbelen J, Stillaert FB, Monstrey S. The use of platelet-rich plasma in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg. 2013;66(3):301-11.
9. Redler LH, Thompson SA, Hsu SH, Ahmad CS, Levine WN. Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. Phys Sportsmed. 2011;39(1):42-51.
10. Cieslik Bielecka A, Choukroun J, Odin G, DohanEhrenfest DM. L-PRP/L-PRF in esthetic plastic surgery, regenerative medicine of the skin and chronic wounds. Curr Pharm Biotechnol. 2012;13(7):1266-77.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.